title: Beneficial Effects of Hypoxic Preconditioning on Human Umbilical Cord Mesenchymal Stem Cells.
abstract: As human umbilical cord mesenchymal stem cells (hUC-MSCs) transplanation may be promising in heart failure treatment, it is important to know whether hypoxic preconditioning (HP) promote hUC-MSCs proliferation and differentiation and protect them against chemical hypoxic damages. This study aimed to investigate the effects of HP on proliferation and differentiation of human umbilical cord mesenchymal stem cells (hUC-MSCs). The study also aimed to confirm our hypothesis that HP could promote hUC-MSCs proliferation and differentiation to cardiomyocyte-like cells as well as effectively protecting hUC-MSCs and cardiomyocyte-like cells against chemical hypoxic damages. Isolated hUC-MSCs were cultured in hypoxia at 1%, 3% and 5% O₂ for 72 hours. 5-azacytidine (5-AZA) induced differentiation of hUC-MSCs to cardiomyocyte-like cells was determined by streptavidin-perosidase (SP) immunohistochemical staining and the content of troponin (TnI). Flow cytometry was used to measure cell cycle in hUC-MSCs and cardiomyocyte-like cells. The mitochondrial membrane potential (ΔΨ(m)) and mitochondrial Ca²⁺ concentration ([Ca²⁺](m)), were measured in hUC-MSCs and cardiomyocyte-like cells during chemical hypoxia induced by cobalt chloride (100 μmol/L). HP optimally promoted the proliferation of hUC-MSCs at 3% O₂ and enhanced the differentiation of hUC-MSCs to cardiomyocyte-like cells by 5-AZA in a concentration-dependent manner. The cell cycle distribution of cardiomyocyte-like cells, but not hUC-MSCs, was clearly changed by HP. Chemical hypoxic damage, decreased ΔΨ(m) and increased [Ca²⁺](m), were alleviated significantly in HP-treated cells compared with the normaxia-treated cells. The results demonstrate that HP promoted hUC-MSCs proliferation and differentiation to cardiomyocyte-like cells, and protected both cell types against chemical hypoxic damage.
authors.affiliation: Department of Physiology, Hebei Medical University, Shijiazhuang 050017, Hebei, People's Republic of China.|Department of Cardiology, Bethune International Peace Hospital, Shijiazhuang 050082, Hebei, People's Republic of China.
authors.forename: Li
authors.initials: L
authors.lastname: Zhang
authors.affiliation: Department of Physiology, Hebei Medical University, Shijiazhuang 050017, Hebei, People's Republic of China.
authors.forename: Jing
authors.initials: J
authors.lastname: Yang
authors.affiliation: Department of Physiology, Hebei Medical University, Shijiazhuang 050017, Hebei, People's Republic of China.
authors.forename: Yan-Ming
authors.initials: YM
authors.lastname: Tian
authors.affiliation: Department of Gynaecology and Obstetrics, the Fourth Hospital, Hebei Medical University, Shijiazhuang 050000, Hebei, People's Republic of China.
authors.forename: Hui
authors.initials: H
authors.lastname: Guo
authors.affiliation: Department of Physiology, Hebei Medical University, Shijiazhuang 050017, Hebei, People's Republic of China.|Hebei Collaborative Innovation Center for Cardio-cerebrovascular Disease, Shijiazhuang 050000, Hebei, People's Republic of China.
authors.forename: Yi
authors.initials: Y
authors.lastname: Zhang
mesh_terms: D002453:Cell Cycle; D002454:Cell Differentiation; D049109:Cell Proliferation; D002478:Cells, Cultured; D006801:Humans; D000860:Hypoxia; D019194:Ischemic Preconditioning; D059630:Mesenchymal Stem Cells / Q000502:physiology*; D032383:Myocytes, Cardiac / Q000648:ultrastructure*